KRYSTAL KENT: Open Payments
NPI 1447866389 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 25 payments from 9 companies in 2025. Trend: 2023 $221 · 2024 $391 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $96 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 3 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: JARDIANCE, BREZTRI, SHINGRIX, FARXIGA, ELIQUIS, VOQUEZNA, NURTEC ODT, LOKELMA.
Industry payments across TX — which companies pay providers there.
